All articles by Kezia Parkins

Kezia Parkins

Kezia Parkins is the lead editor for Medical Device Network and Medical Technology Magazine. She is an experienced healthcare writer and editor with special interests in MedTech, clinical trials, patient centricity and global health equality.

Magazine: is the metaverse the next frontier in clinical trials?

In this issue, we take a dive into the metaverse - a decentralised virtual world that is set to revolutionise…
Magazine: A choppy history of racial bias in oximetry

The latest issue of Medical Technology Focus is out now. Read it for free on all devices. Covid-19 has put…
A choppy history of racial bias in oximetry

Last November, health secretary and UK MP Sajid Javid announced a review into systematic racism and gender bias in medical…
Women’s health clinical trials: breaking down barriers through decentralisation

Patient recruitment is one of the most challenging aspects of running clinical trials. Certain socioeconomic factors, such as the disproportionate…
Covid-19 spurred on the self-testing revolution

Self-testing has become a regular part of life thanks to Covid-19. The world relied on lateral flow tests (LFTs) to…

Is FDA LDT surveillance set to improve as VALID Act heads to resolution?

Need to know: The VALID Act would create a new risk-based framework for regulating lab-developed tests including a new category…
UK’s first digital health training programme launches for NHS frontline staff

This week, the Digital Health Academy became freely available for all healthcare professionals in the UK to upskill frontline workers…
Covid-19: Mental health app growth reveals unmet needs

Need to Know: ORCHA, the Organisation for the Review of Care and Health Apps saw a 6,500% increase in healthcare…
IQVIA on AI’s potential to match patients to trials and improve trial diversity

Artificial intelligence (AI) is increasingly being harnessed to increase the operational efficiency of clinical trials, accelerate drug discovery and reduce…
The Theranos saga: a wake-up call for the lab-developed test market

Stanford School of Engineering dropout, Elizabeth Holmes, fooled the world with her seemingly revolutionary blood test developed at the tender…